Stryker Corporation (SYK) : Wendell David Associates Inc reduced its stake in Stryker Corporation by 0.56% during the most recent quarter end. The investment management company now holds a total of 131,474 shares of Stryker Corporation which is valued at $16,087,159 after selling 745 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Jul 18, 2016.Stryker Corporation makes up approximately 3.08% of Wendell David Associates Inc’s portfolio.
Other Hedge Funds, Including , Cribstone Capital Management boosted its stake in SYK in the latest quarter, The investment management firm added 1,467 additional shares and now holds a total of 4,705 shares of Stryker Corporation which is valued at $575,704. Stryker Corporation makes up approx 0.36% of Cribstone Capital Management’s portfolio.Founders Capital Management reduced its stake in SYK by selling 158 shares or 0.52% in the most recent quarter. The Hedge Fund company now holds 30,209 shares of SYK which is valued at $3,674,019. Stryker Corporation makes up approx 2.01% of Founders Capital Management’s portfolio.Cue Financial Group reduced its stake in SYK by selling 165 shares or 1.86% in the most recent quarter. The Hedge Fund company now holds 8,719 shares of SYK which is valued at $1,068,165. Stryker Corporation makes up approx 0.89% of Cue Financial Group’s portfolio.
Stryker Corporation opened for trading at $122.3 and hit $122.65 on the upside on Wednesday, eventually ending the session at $122.36, with a gain of 0.49% or 0.6 points. The heightened volatility saw the trading volume jump to 12,97,449 shares. Company has a market cap of $45,760 M.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.